HSHHSH Health Technology Supplier Hub
Home › Suppliers › Waystar

Waystar

HQ United States · North America

Directory listing. Financial health and risk summaries come from public sources only (see below); products have not been catalogued yet. Source: HSH editorial list from public company information, November 2026 — awaiting verification.

At a glance

Financial health
Band: Strong
Customer rating
No reviews yet

Financial health

Band: StrongListed: WAY

FY2025 revenue $1.10bn (+17.0%); operating margin 22.7%; net income $112.1m.

Balance sheet figures not captured from release.

Source: official results release · Year ended 2025-12-31 · Band from the latest full-year operating margin in official results: 10% or more Strong, 0–10% Fair, below 0 Weak. Where operating profit is not published, the stated alternative margin is used. Not assessed means no usable public figures.

YearRevenueGrowthOperating profitNet incomeCovers
FY2025US$1.1bn+17.0%US$249.3mUS$112.1mWaystar

Products & services

Products not yet catalogued.

Financial

FY2025 revenue $1.10bn (+17.0%); operating margin 22.7%; net income $112.1m.

Balance sheet figures not captured from release.

Researched 8 Nov 2026

Adverse media

Not yet researched.

Cyber & information governance

Not yet researched.

Regulatory & clinical safety

Not yet researched.

Contract performance

Not yet researched.

Competitors

No competitors linked yet.

Customer reviews

No reviews yet